Uncovering Denials: OIG Reports Reveal Alarming Trends in Medicaid Managed Care Plans

Published in Government Relations on August 25, 2023

In 2022, the OIG released a report outlining their findings which concluded that Medicare Advantage plans were routinely denying authorizations requests and claims for items that would be covered by traditional Medicare Fee For Service (FFS). On July 17, 2023, the OIG released a similar report which shows something similar may be happening within Medicaid Manage Care plans. The three main things that they concluded from their research was that within Medicaid managed care programs:

  1. A high number and rate of denied prior authorization (PA) requests by some MCOs, some of which very likely should have been approved,
  2. limited oversight of prior authorization denials in most States, and
  3. limited access to external medical reviews and a cumbersome appeal and/or state fair hearing process, which may deter providers and or Medicaid patients from pursuing that option.

While conducting their analysis, the OIG looked at authorization and claims data from seven parent companies, namely Molina, CareSource, UHC, Centene, Anthem/Elevance, Aetna, and AmeriHealth Caritas. These parent companies represent 115 Medicaid MCOs in 37 states and cover nearly 30 million people[AR1] , roughly 36% of the total number of Medicaid lives. Some additional findings and statistics from the OIG’s Medicaid report included:

  • MCOs denied one out of eight (12.5%) requests for prior authorization (PA) in 2019.
  • MCOs fully or partially denied approximately 2.2 million PA requests in 2019.
  • 12 MCOs had PA denial rates greater than 25%—twice the overall rate.
  • Most State Medicaid agencies reported that they did not routinely review the appropriateness of a sample of MCO denials of PA requests.
  • Many states did not collect and monitor data on these decisions.
  • Absence of oversight of MCO decisions on PA requests presents a limitation that can allow inappropriate denials to go undetected in Medicaid managed care.
  • Most State Medicaid agencies reported they do not have a mechanism for patients or providers to submit a PA denial to an external medical reviewer independent of the MCO.
  • Although all State Medicaid agencies are required to offer State fair hearings as an appeal option, these administrative hearings may be difficult to navigate and burdensome on Medicaid patients. The OIG reported that Medicaid enrollees appealed only a small portion of PA denials to either their MCOs or to State fair hearings.
  • Seven of Molina’s 12 MCOs had PA denial rates greater than 25%.

As many of you are aware, VGM has participated in several meetings and discussions with CMS over the past 12 months around the topics of improper denials of PA and claims within managed Medicare and managed Medicaid, general lack of oversight for these plans, and overall network adequacy. We will continue to use findings like the ones outlined above along with other examples provided by our members to continue our discussions with CMS representatives, with the goal being to reduce or eliminate these issues within managed care in the future. Please continue to provide us with those examples of improper denials and access-to-care issues resulting from inadequate provider networks.

From Our Experts

Proposed Rule Suggests Significant Change To Accreditation Process thumbnail Proposed Rule Suggests Significant Change To Accreditation Process The recently released proposed rule CMS-1828-P contains a significant change that could reshape how suppliers navigate accreditation. The rule proposes a major change that would require suppliers to be surveyed and reaccredited annually instead of the current three (3) year cadence. This proposal raises substantial questions about both operational feasibility and cost implications. August Of Action: Your Chance To Connect With Congress thumbnail August Of Action: Your Chance To Connect With Congress It's time to take advantage of August Of Action—a perfect opportunity to make your voice heard. Every summer, federal legislators return to their home states during the Congressional recess. While it gives them a break from Washington D.C., it's primarily a time for them to connect with constituents like you. HR1 Passes House, Advances to President Trump's Desk for Signature thumbnail HR1 Passes House, Advances to President Trump's Desk for Signature After extensive negotiations and partisan debate, the House has officially passed HR1, clearing the path for the bill to be signed into law by President Donald Trump. The legislation, which aims to reduce federal healthcare expenditures, contains several provisions that may impact the durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS) industry. CMS files the Proposed Rule that sheds light on the next round of the Competitive Bidding Program thumbnail CMS files the Proposed Rule that sheds light on the next round of the Competitive Bidding Program On June 30, 2025, CMS filed the anticipated Proposed Rule that includes updates to the Competitive Bidding Program (CBP). Public comments are due 60 days from June 30, 2025. Below is a high-level summary of the rule. It is critical to note that, according to the Proposed Rule Fact Sheet dated June 30, 2025, CMS has stated that they have not announced the specific product categories they are bidding or the specific timeframe for the next competition. Those specifics will be forthcoming in a fu Senate Narrowly Passes HR1, Sending It Back to House for Final Approval thumbnail Senate Narrowly Passes HR1, Sending It Back to House for Final Approval President Donald Trump's sweeping legislative package, formally titled the One Big, Beautiful Bill Act, now referred to as HR1., cleared the Senate today in a dramatic 51–50 vote, with Vice President JD Vance casting the tie-breaking vote. The bill now returns to the House, where lawmakers must decide whether to adopt the Senate's revised version or negotiate further changes before it can reach the president's desk. Several Prominent Medicaid Provisions in Senate's Budget Bill Deemed in Violation of Byrd Rule thumbnail Several Prominent Medicaid Provisions in Senate's Budget Bill Deemed in Violation of Byrd Rule Senate Parliamentarian Elizabeth MacDonough advised this week that multiple Medicaid provisions in the Senate's reconciliation bill would violate Senate procedure by violating the Byrd Rule. The Byrd Rule is a Senate-specific procedural process that allows Senators to prevent or block inclusion of extraneous provisions in reconciliation bills. Other provisions are still under review. Evaluating the Value of a Payer Contract thumbnail Evaluating the Value of a Payer Contract In our last article, Key Payers Denied Your Application Citing Their Network Is Closed – Now What?, we discussed strategies for addressing payer contracting denials due to a closed network. As indicated, this process can be an extremely time-consuming exercise with no guarantees and mixed results. Below are a few things to consider as you evaluate whether a contract is worth the extra effort. Webinar: Webinar: "Navigating The New CMS Landscape: RADs, HMVs, and Supplier Survival" on June 25 at 1 p.m. CT. The Centers for Medicare & Medicaid Services (CMS) has released its final National Coverage Determination (NCD) for RADs and HMVs used in treating chronic respiratory failure due to COPD. While the rule potentially expands access to bilevel ST therapy (RADs), it also introduces complex compliance requirements, tighter usage criteria, and increased documentation burdens—without additional reimbursement.